Literature DB >> 2498649

Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains.

A Himmler1, D Drechsel, M W Kirschner, D W Martin.   

Abstract

Tau proteins consist of a family of proteins, heterogeneous in size, which associate with microtubules in vivo and are induced during neurite outgrowth. In humans, tau is one of the major components of the pathognomonic neurofibrillary tangles in Alzheimer's disease brain. Screening of a cDNA library prepared from bovine brain led to the isolation of several cDNA clones encoding tau proteins with different N termini and differing by insertions or deletions, suggesting differential splicing of the tau transcripts. One of the N-terminal domains and the repeated C-terminal domain of the encoded tau proteins are recognized by polyclonal antibodies to bovine tau. The bovine tau proteins are highly homologous to murine and human tau, especially within the repeated C-terminal domain. Compared with murine and human tau, bovine tau contains the insertion of three longer segments, one of which is an additional characteristic repeat. Portions of tau proteins generated by in vitro translation were used to show that these repeats represent tubulin-binding domains, two of which are sufficient to bind to microtubules assembled from purified tubulin in the presence of taxol.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2498649      PMCID: PMC362554          DOI: 10.1128/mcb.9.4.1381-1388.1989

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  40 in total

1.  Alzheimer's neurofibrillary tangles contain unique epitopes and epitopes in common with the heat-stable microtubule associated proteins tau and MAP2.

Authors:  S H Yen; D W Dickson; A Crowe; M Butler; M L Shelanski
Journal:  Am J Pathol       Date:  1987-01       Impact factor: 4.307

2.  Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease.

Authors:  Y Ihara; N Nukina; R Miura; M Ogawara
Journal:  J Biochem       Date:  1986-06       Impact factor: 3.387

3.  Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.

Authors:  I Grundke-Iqbal; K Iqbal; M Quinlan; Y C Tung; M S Zaidi; H M Wisniewski
Journal:  J Biol Chem       Date:  1986-05-05       Impact factor: 5.157

4.  Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

Authors:  I Grundke-Iqbal; K Iqbal; Y C Tung; M Quinlan; H M Wisniewski; L I Binder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

5.  Visualization of the dynamic instability of individual microtubules by dark-field microscopy.

Authors:  T Horio; H Hotani
Journal:  Nature       Date:  1986 Jun 5-11       Impact factor: 49.962

6.  Association of tau protein with microtubules in living cells.

Authors:  D Drubin; S Kobayashi; M Kirschner
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

7.  3' non-coding region sequences in eukaryotic messenger RNA.

Authors:  N J Proudfoot; G G Brownlee
Journal:  Nature       Date:  1976-09-16       Impact factor: 49.962

8.  Dynamic and stable populations of microtubules in cells.

Authors:  E Schulze; M Kirschner
Journal:  J Cell Biol       Date:  1987-02       Impact factor: 10.539

9.  Nerve growth factor-induced neurite outgrowth in PC12 cells involves the coordinate induction of microtubule assembly and assembly-promoting factors.

Authors:  D G Drubin; S C Feinstein; E M Shooter; M W Kirschner
Journal:  J Cell Biol       Date:  1985-11       Impact factor: 10.539

10.  Tau protein function in living cells.

Authors:  D G Drubin; M W Kirschner
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

View more
  169 in total

1.  Inhibition of c-Jun kinase provides neuroprotection in a model of Alzheimer's disease.

Authors:  Steven P Braithwaite; Ralf S Schmid; Dong Ning He; Mei-Li A Sung; Seongeon Cho; Lynn Resnick; Michael M Monaghan; Warren D Hirst; Christian Essrich; Peter H Reinhart; Donald C Lo
Journal:  Neurobiol Dis       Date:  2010-05-06       Impact factor: 5.996

Review 2.  Targeting tau protein in Alzheimer's disease.

Authors:  Cheng-Xin Gong; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  Drugs Aging       Date:  2010-05       Impact factor: 3.923

3.  Primary structure of high molecular weight tau present in the peripheral nervous system.

Authors:  D Couchie; C Mavilia; I S Georgieff; R K Liem; M L Shelanski; J Nunez
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

4.  Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau.

Authors:  D N Drechsel; A A Hyman; M H Cobb; M W Kirschner
Journal:  Mol Biol Cell       Date:  1992-10       Impact factor: 4.138

5.  Specific macromolecular interactions between tau and the microtubule system.

Authors:  G A Farías; C Vial; R B Maccioni
Journal:  Mol Cell Biochem       Date:  1992-05-13       Impact factor: 3.396

6.  Role for neuronal insulin resistance in neurodegenerative diseases.

Authors:  Markus Schubert; Dinesh Gautam; David Surjo; Kojihiko Ueki; Stephanie Baudler; Dominic Schubert; Tatsuya Kondo; Jens Alber; Norbert Galldiks; Eckehardt Küstermann; Saskia Arndt; Andreas H Jacobs; Wilhelm Krone; C Ronald Kahn; Jens C Brüning
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-23       Impact factor: 11.205

7.  Wild type and P301L mutant Tau promote neuro-inflammation and α-Synuclein accumulation in lentiviral gene delivery models.

Authors:  Preeti J Khandelwal; Sonya B Dumanis; Alexander M Herman; G William Rebeck; Charbel E-H Moussa
Journal:  Mol Cell Neurosci       Date:  2011-09-14       Impact factor: 4.314

8.  Pseudohyperphosphorylation has differential effects on polymerization and function of tau isoforms.

Authors:  Benjamin Combs; Kellen Voss; T Chris Gamblin
Journal:  Biochemistry       Date:  2011-10-17       Impact factor: 3.162

9.  Expression of Tau protein and Tau mRNA in the cerebellum during axonal outgrowth.

Authors:  D Couchie; F Legay; J Guilleminot; F Lebargy; J P Brion; J Nunez
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

10.  Parkin attenuates wild-type tau modification in the presence of beta-amyloid and alpha-synuclein.

Authors:  Charbel E-H Moussa
Journal:  J Mol Neurosci       Date:  2008-06-17       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.